메뉴 건너뛰기




Volumn 5, Issue 8, 2007, Pages 716-717

Treatment of psoriasis with fumaric acid esters (Fumaderm®);Therapie der psoriasis mit fumarsäureestern (Fumaderm®)

Author keywords

[No Author keywords available]

Indexed keywords

COLECALCIFEROL; CORTICOSTEROID DERIVATIVE; DITHRANOL; EMOLLIENT AGENT; FUMADERM; FUMARIC ACID DERIVATIVE; FUMARIC ACID ESTER; RETINOID; SALICYLIC ACID; TAR; UNCLASSIFIED DRUG;

EID: 34547129333     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/j.1610-0387.2007.06346.x     Document Type: Review
Times cited : (67)

References (8)
  • 1
    • 0029664707 scopus 로고    scopus 로고
    • Das Wirkungs- und Sicherheitsprofil von Fumarsäureestern in der oralen Langzeittherapie bei schwerer therapieresistenter Psoriasis vulgaris
    • Altmeyer P, Hartwig R, Matthes U. Das Wirkungs- und Sicherheitsprofil von Fumarsäureestern in der oralen Langzeittherapie bei schwerer therapieresistenter Psoriasis vulgaris. Hautarzt 1996 47 : 190 196.
    • (1996) Hautarzt , vol.47 , pp. 190-196
    • Altmeyer, P.1    Hartwig, R.2    Matthes, U.3
  • 2
    • 0029826492 scopus 로고    scopus 로고
    • Verlaufsbeobachtungen der Lymphozytensubpopulationen bei Psoriasis-Patienten unter oraler Therapie mit Fumaraten
    • Altmeyer P, Höxtermann S, Auer T. Verlaufsbeobachtungen der Lymphozytensubpopulationen bei Psoriasis-Patienten unter oraler Therapie mit Fumaraten. Akt Dermatol 1996 22 : 272 277.
    • (1996) Akt Dermatol , vol.22 , pp. 272-277
    • Altmeyer, P.1    Höxtermann, S.2    Auer, T.3
  • 3
    • 20244383720 scopus 로고
    • Antipsoriatic effect of fumaric acid derivatives. Results of a multicenter double-blind study in 100 patients
    • Altmeyer P, Matthes U, Pawlak F, Hoffmann K, Frosch PJ, Ruppert P et al. Antipsoriatic effect of fumaric acid derivatives. Results of a multicenter double-blind study in 100 patients. J Am Acad Dermatol 1994 30 : 977 981.
    • (1994) J Am Acad Dermatol , vol.30 , pp. 977-981
    • Altmeyer, P.1    Matthes, U.2    Pawlak, F.3    Hoffmann, K.4    Frosch, P.J.5    Ruppert, P.6
  • 4
    • 0042413498 scopus 로고    scopus 로고
    • Long-term safety aspects of systemic therapy with fumaric acid esters in severe psoriasis
    • Hofnagel JJ, Thio HB, Willemze R, Bouwes Bavinck JN. Long-term safety aspects of systemic therapy with fumaric acid esters in severe psoriasis. Br J Dermatol 2003 149 : 363 369.
    • (2003) Br J Dermatol , vol.149 , pp. 363-369
    • Hofnagel, J.J.1    Thio, H.B.2    Willemze, R.3    Bouwes Bavinck, J.N.4
  • 5
    • 0036978134 scopus 로고    scopus 로고
    • Topical calcipotriol plus oral fumaric acid is more effective and faster acting than oral fumaric acid monotherapy in the treatment of severe chronic plaque psoriasis vulgaris
    • Gollnick H, Altmeyer P, Kaufmann R, Ring J, Christophers E, Pavel S et al. Topical calcipotriol plus oral fumaric acid is more effective and faster acting than oral fumaric acid monotherapy in the treatment of severe chronic plaque psoriasis vulgaris. Dermatology 2002 205 : 46 53.
    • (2002) Dermatology , vol.205 , pp. 46-53
    • Gollnick, H.1    Altmeyer, P.2    Kaufmann, R.3    Ring, J.4    Christophers, E.5    Pavel, S.6
  • 6
    • 0031896129 scopus 로고    scopus 로고
    • Treatment of psoriasis with fumaric acid esters. Results of a prospective multicenter study
    • Mrowietz U, Christophers E, Altmeyer P. Treatment of psoriasis with fumaric acid esters. Results of a prospective multicenter study. Br J Dermatol 1997 138 : 456 460.
    • (1997) Br J Dermatol , vol.138 , pp. 456-460
    • Mrowietz, U.1    Christophers, E.2    Altmeyer, P.3
  • 7
    • 0032858530 scopus 로고    scopus 로고
    • Treatment of severe psoriasis with fumaric acid esters: Scientific background and guidelines for therapeutic use
    • Mrowietz U, Christophers E, Altmeyer P. Treatment of severe psoriasis with fumaric acid esters: scientific background and guidelines for therapeutic use. Br J Dermatol 1999 141 : 424 429.
    • (1999) Br J Dermatol , vol.141 , pp. 424-429
    • Mrowietz, U.1    Christophers, E.2    Altmeyer, P.3
  • 8
    • 33751545239 scopus 로고    scopus 로고
    • S3-Leitlinie zur Therapie der Psoriasis vulgaris
    • Nast A, Kopp IB, Augustin M et al., S3-Leitlinie zur Therapie der Psoriasis vulgaris. J Dtsch Dermatol Ges 2006 4 : S1 S126.
    • (2006) J Dtsch Dermatol Ges , vol.4
    • Nast, A.1    Kopp, I.B.2    Augustin, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.